GMED

Globus Medical

Price

$88.34

return (12m)

45.46%

p/e

18.00

p/bv

2.49

DIVIDEND YIELD

0.00%

GMED price

Globus Medical

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment GMED

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

16.57%

3 months

4.16%

1 year

45.46%

2 years

27.77%

5 years

13.69%

10 years

285.93%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals GMED

Valuation

P/E

18.00

Sector 7.79

Industry 7.79

P/BV

2.49

Sector 2.11

Industry 2.11

P/Revenue (PSR)

3.78

Sector 2.22

Industry 2.22

EV/EBITDA

Sector -156.98

Industry -156.98

EV/EBIT

Sector -1,355,776,171.42

Industry -1,355,776,171.42

P/EBITDA

24.65

Sector 2.51

Industry 2.51

P/EBIT

90.67

Sector 0.34

Industry 0.34

P/Total Assets

2.16

Sector 1.00

Industry 1.00

P/Net Current Assets

7.94

Sector -3.84

Industry -3.84

P/Working Capital

6.84

Sector -5,077.26

Industry -5,077.26

EPS

4.77

Sector 0.67

Industry 0.67

BVPS

34.51

Sector 10.17

Industry 10.17

Efficiency

Gross Margin

68.55%

Sector 32.61%

Industry 32.61%

EBITDA Margin

Sector -284.80%

Industry -284.80%

EBIT Margin

-17.65%

Sector -4.02%

Industry -4.02%

Operating Margin

20.75%

Sector 4.45%

Industry 4.45%

Net Profit Margins

20.98%

Sector 2.39%

Industry 2.39%

Asset Turnover

0.14

Sector 0.11

Industry 0.11

Profitability

ROE

13.83%

Sector 2.05%

Industry 2.05%

ROA

12.02%

Sector -0.90%

Industry -0.90%

ROIC

Sector -118.95%

Industry -118.95%

Dividends

Dividend yield

0.00%

Sector 0.60%

Industry 0.60%

Payout

0.00%

Sector 11.53%

Industry 11.53%

Debt

Current Ratio

4.62

Sector 1.44

Industry 1.44

Net Debt / EBITDA

Sector -39,522,158.34

Industry -39,522,158.34

Net Debt / EBIT

Sector -31.03

Industry -31.03

Net Debt / Equity

Sector -0.72

Industry -0.72

Gross Debt / Equity

Sector 0.21

Industry 0.21

Equity/Assets

0.87

Sector 0.43

Industry 0.43

Liabilities/Assets

0.13

Sector 0.52

Industry 0.52

Growth

5Y Revenue CAGR

26.83%

Sector -

Industry -

5Y Earnings CAGR

34.62%

Sector -

Industry -

FAIR VALUE OF Globus Medical ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$88.34

Fair Value

$60.86

Upside Return potential.

-31.11%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals GMED

DRAG THE FRAME TO SEE MORE DATA

GMED Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Globus Medical

Globus Medical

Average Investor10 user rating

4.0 (1 people)

United States

23 years

Founded: 2003

2012

Time since IPO - 14 years

6.000

Employees

Globus Medical (United States) is listed on the Nasdaq and has a market capitalization of $11.87 billion, with shareholders equity totaling $4.77 billion.

The company employs approximately 6.000 people and operates in the Others sector, within the Others industry.

Over the past 12 months, Globus Medical reported $3.14 billion in revenue, generating net income of $659.73 million.

Key financial metrics include a P/E ratio of 18.00, a price-to-book (P/B) ratio of 2.49, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker GMED.

Market cap

$11.87 billion

Net worth

$4.77 billion

$4,768,603,000.00

Assets

$5.49 billion

$5,488,258,000.00

Total Shares Outstanding

138.19 million

138,191,000

Average Daily Trading Volume

$1.75 million

$1,750,128.00

Sector

Others

Industry

Others

GMED

GMED revenue and profits

Financial Results GMED

DRAG THE FRAME TO SEE MORE DATA

GMED cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$388.61 33,84% (12M)

P/E

25.58

2.23%

ROE

13.33%

P/BV

3.41

SHEL - Shell PLC ADR

$92.77 34,82% (12M)

P/E

9.65

3.30%

ROE

14.29%

P/BV

1.38

STLA - Stellantis NV

$5.43 --44,42% (12M)

P/E

-0.61

0.00%

ROE

-35.93%

P/BV

0.22

COR - Cencora Inc.

$317.10 5,40% (12M)

P/E

22.86

0.76%

ROE

81.04%

P/BV

18.52

SSNLF - Samsung Electronics Co Ltd

$- -0,00% (12M)

P/E

13.54

4.85%

ROE

1.69%

P/BV

0.23

ALIZY - Allianz SE ADR

$51.08 --13,60% (12M)

P/E

14.12

2.66%

ROE

17.89%

P/BV

2.53

TTE - TotalEnergies SE ADR

$90.07 54,62% (12M)

P/E

7.06

4.61%

ROE

21.42%

P/BV

1.51

NSRGY - Nestle SA ADR

$99.21 9,18% (12M)

P/E

11.98

4.01%

ROE

58.05%

P/BV

6.96